Articles - 1hii mentioned but not cited (6)
- Extent of structural asymmetry in homodimeric proteins: prevalence and relevance. Swapna LS, Srikeerthana K, Srinivasan N. PLoS One 7 e36688 (2012)
- Comparing interfacial dynamics in protein-protein complexes: an elastic network approach. Zen A, Micheletti C, Keskin O, Nussinov R. BMC Struct Biol 10 26 (2010)
- Automated site preparation in physics-based rescoring of receptor ligand complexes. Rapp CS, Schonbrun C, Jacobson MP, Kalyanaraman C, Huang N. Proteins 77 52-61 (2009)
- A knowledge-guided strategy for improving the accuracy of scoring functions in binding affinity prediction. Cheng T, Liu Z, Wang R. BMC Bioinformatics 11 193 (2010)
- Dimer Interface Organization is a Main Determinant of Intermonomeric Interactions and Correlates with Evolutionary Relationships of Retroviral and Retroviral-Like Ddi1 and Ddi2 Proteases. Mótyán JA, Miczi M, Tőzsér J. Int J Mol Sci 21 E1352 (2020)
- Analysis of the HIV-2 protease's adaptation to various ligands: characterization of backbone asymmetry using a structural alphabet. Triki D, Cano Contreras ME, Flatters D, Visseaux B, Descamps D, Camproux AC, Regad L. Sci Rep 8 710 (2018)
Reviews citing this publication (1)
- Dimerization inhibitors of HIV-1 reverse transcriptase, protease and integrase: a single mode of inhibition for the three HIV enzymes? Camarasa MJ, Velázquez S, San-Félix A, Pérez-Pérez MJ, Gago F. Antiviral Res 71 260-267 (2006)
Articles citing this publication (17)
- How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease. Prabu-Jeyabalan M, Nalivaika E, Schiffer CA. J Mol Biol 301 1207-1220 (2000)
- Relation between sequence and structure of HIV-1 protease inhibitor complexes: a model system for the analysis of protein flexibility. Zoete V, Michielin O, Karplus M. J Mol Biol 315 21-52 (2002)
- Crystal structure of an in vivo HIV-1 protease mutant in complex with saquinavir: insights into the mechanisms of drug resistance. Hong L, Zhang XC, Hartsuck JA, Tang J. Protein Sci 9 1898-1904 (2000)
- Emergence of drug resistance mutations in human immunodeficiency virus type 2-infected subjects undergoing antiretroviral therapy. Rodés B, Holguín A, Soriano V, Dourana M, Mansinho K, Antunes F, González-Lahoz J. J Clin Microbiol 38 1370-1374 (2000)
- Mapping the energetics of water-protein and water-ligand interactions with the "natural" HINT forcefield: predictive tools for characterizing the roles of water in biomolecules. Amadasi A, Spyrakis F, Cozzini P, Abraham DJ, Kellogg GE, Mozzarelli A. J Mol Biol 358 289-309 (2006)
- Polymorphism and drug-selected mutations in the protease gene of human immunodeficiency virus type 2 from patients living in Southern France. Colson P, Henry M, Tourres C, Lozachmeur D, Gallais H, Gastaut JA, Moreau J, Tamalet C. J Clin Microbiol 42 570-577 (2004)
- Identification of the minimal conserved structure of HIV-1 protease in the presence and absence of drug pressure. Ceccherini-Silberstein F, Erba F, Gago F, Bertoli A, Forbici F, Bellocchi MC, Gori C, D'Arrigo R, Marcon L, Balotta C, Antinori A, Monforte AD, Perno CF. AIDS 18 F11-9 (2004)
- DREAM++: flexible docking program for virtual combinatorial libraries. Makino S, Ewing TJ, Kuntz ID. J Comput Aided Mol Des 13 513-532 (1999)
- Getting it right: modeling of pH, solvent and "nearly" everything else in virtual screening of biological targets. Kellogg GE, Fornabaio M, Spyrakis F, Lodola A, Cozzini P, Mozzarelli A, Abraham DJ. J Mol Graph Model 22 479-486 (2004)
- Synthesis of Atropisomeric Hydrazides by One-Pot Sequential Enantio- and Diastereoselective Catalysis. Portolani C, Centonze G, Luciani S, Pellegrini A, Righi P, Mazzanti A, Ciogli A, Sorato A, Bencivenni G. Angew Chem Int Ed Engl 61 e202209895 (2022)
- A ligand-based approach for the in silico discovery of multi-target inhibitors for proteins associated with HIV infection. Speck-Planche A, Kleandrova VV, Luan F, Cordeiro MN. Mol Biosyst 8 2188-2196 (2012)
- News Atazanavir sulphate. Raja A, Lebbos J, Kirkpatrick P. Nat Rev Drug Discov 2 857-858 (2003)
- The 80's loop (residues 78 to 85) is important for the differential activity of retroviral proteases. Stebbins J, Towler EM, Tennant MG, Deckman IC, Debouck C. J Mol Biol 267 467-475 (1997)
- Exploration of the effect of sequence variations located inside the binding pocket of HIV-1 and HIV-2 proteases. Triki D, Billot T, Visseaux B, Descamps D, Flatters D, Camproux AC, Regad L. Sci Rep 8 5789 (2018)
- Impacts of drug resistance mutations on the structural asymmetry of the HIV-2 protease. Laville P, Fartek S, Cerisier N, Flatters D, Petitjean M, Regad L. BMC Mol Cell Biol 21 46 (2020)
- Development and validation of a stability-indicating RP-HPLC method for estimation of atazanavir sulfate in bulk. Dey S, Subhasis Patro S, Suresh Babu N, Murthy PN, Panda SK. J Pharm Anal 7 134-140 (2017)
- Structural Impacts of Drug-Resistance Mutations Appearing in HIV-2 Protease. Laville P, Petitjean M, Regad L. Molecules 26 611 (2021)
Related citations provided by authors (1)
- Novel Pseudosymmetric Inhibitors of HIV-1 Protease. Fassler A, Rosel J, Tintelnot-Blomley M, Alteri E, Bold G, Lang M Bioorg. Med. Chem. Lett. 3 2837- (1993)